{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:34:28Z","timestamp":1793712868291,"version":"4.6.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017035","name":"Center for AIDS Research, Johns Hopkins University","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100017035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG081148"],"award-info":[{"award-number":["R56AG081148"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG074839"],"award-info":[{"award-number":["R56AG074839"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG053100"],"award-info":[{"award-number":["R01AG053100"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.annepidem.2026.110292","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:29:10Z","timestamp":1790098150000},"page":"110292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of an early body mass index maintenance intervention at ART initiation on diabetes risk: Insights from a computer simulation study"],"prefix":"10.1016","volume":"123","author":[{"given":"Parastu","family":"Kasaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Humes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Gerace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine R.","family":"Lesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Kurgansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Koethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Rebeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassem","family":"Bourgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Erlandson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Gebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.annepidem.2026.110292_bib1","doi-asserted-by":"crossref","first-page":"e2334","DOI":"10.1093\/cid\/ciaa1904","article-title":"CD4 count at entry into care and at antiretroviral therapy prescription among adults with human immunodeficiency virus in the United States, 2005-2018","volume":"73","author":"Lee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110292_bib2","article-title":"Weight gain and antiretroviral therapy","author":"Bailin","year":"2024","journal-title":"Infect Dis Clin"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/aid.2015.0147","article-title":"Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada","volume":"32","author":"Koethe","year":"2016","journal-title":"AIDS Res Human Retrovir"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110292_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108259","article-title":"Longitudinal trajectories of weight changes among people living with HIV on antiretroviral therapy: A group-based study","volume":"26","author":"Wu","year":"2023","journal-title":"Iscience"},{"key":"10.1016\/j.annepidem.2026.110292_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae191","article-title":"Antiretrovirals and weight change: weighing the evidence","author":"Wohl","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110292_bib6","article-title":"Prevalence of obesity and severe obesity among adults: US Department of Health and Human Services","author":"Hales","year":"2020","journal-title":"Cent Dis Control"},{"key":"10.1016\/j.annepidem.2026.110292_bib7","series-title":"Open Forum Infectious Diseases","article-title":"editors. Changes in body mass index over time in people with and without HIV infection","author":"Lam","year":"2024"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110292_bib8","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/cid\/civ192","article-title":"Weight change after antiretroviral therapy and mortality","volume":"60","author":"Yuh","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110292_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143740","article-title":"Relationship between body mass index and mortality in HIV-infected HAART users in the women's interagency HIV study","volume":"10","author":"Sharma","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110292_bib10","doi-asserted-by":"crossref","first-page":"1138S","DOI":"10.3945\/ajcn.2010.28608D","article-title":"Nutritional aspects of HIV-associated wasting in sub-Saharan Africa","volume":"91","author":"Koethe","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181aa1308","article-title":"AIDS TBCPfCRo. The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy","volume":"51","author":"Shlay","year":"2009","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110292_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110292_bib13","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.annepidem.2026.110292_bib14","series-title":"Open forum infectious diseases","article-title":"editors. Changes in waist circumference in HIV-infected individuals initiating a raltegravir or protease inhibitor regimen: effects of sex and race","author":"Bhagwat","year":"2018"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/aid.2012.0234","article-title":"from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons","volume":"29","author":"Lakey","year":"2013","journal-title":"AIDS Res Human Retrovir"},{"issue":"8","key":"10.1016\/j.annepidem.2026.110292_bib16","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/jac\/dky145","article-title":"Obesity following ART initiation is common and influenced by both traditional and HIV-\/ART-specific risk factors","volume":"73","author":"Bakal","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110292_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1089\/jwh.2017.6717","article-title":"HIV-infected women gain more weight than HIV-infected men following the initiation of antiretroviral therapy","volume":"27","author":"Bares","year":"2018","journal-title":"J Women's Health"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110292_bib18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.annepidem.2026.110292_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/cid\/ciac827","article-title":"Limited weight impact after switching from boosted protease inhibitors to dolutegravir in persons with human immunodeficiency virus with high cardiovascular risk: a post hoc analysis of the 96-week NEAT-022 randomized trial","volume":"76","author":"Waters","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110292_bib20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/QAD.0000000000001495","article-title":"Dolutegravir and weight gain: an unexpected bothering side effect?","volume":"31","author":"Menard","year":"2017","journal-title":"Aids"},{"key":"10.1016\/j.annepidem.2026.110292_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11904-020-00483-5","article-title":"Obesity and weight gain in persons with HIV","volume":"17","author":"Bailin","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110292_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/hiv.13413","article-title":"Obesity and diabetes in people of African ancestry with HIV","volume":"24","author":"Cechin","year":"2023","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11904-022-00642-w","article-title":"Diabetes in HIV: the link to weight gain","volume":"20","author":"Bailin","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004325","article-title":"The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study","volume":"21","author":"Althoff","year":"2024","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAD.0000000000003128","article-title":"The shifting age distribution of people with HIV using antiretroviral therapy in the United States","volume":"36","author":"Althoff","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2026.110292_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.annepidem.2021.08.021","article-title":"Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States","volume":"65","author":"Kasaie","year":"2022","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.annepidem.2026.110292_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.annepidem.2023.09.005","article-title":"Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study","volume":"87","author":"Kasaie","year":"2023","journal-title":"Ann Epidemiol"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110292_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ije\/dyl286","article-title":"Cohort profile: the North American AIDS cohort collaboration on research and design (NA-ACCORD)","volume":"36","author":"Gange","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110292_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hiv.12294","article-title":"Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D: A: D study","volume":"17","author":"Achhra","year":"2016","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110292_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","article-title":"Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals","volume":"73","author":"Herrin","year":"2016","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2026.110292_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00705","article-title":"The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality","volume":"9","author":"Kumar","year":"2018","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110292_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glag113","article-title":"The effects of high-intensity interval training versus continuous moderate-intensity exercise on body composition among older adults with HIV","volume":"81","author":"Kulik","year":"2026","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.annepidem.2026.110292_bib33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/09540121.2016.1248347","article-title":"Dropout from physical activity interventions in people living with HIV: a systematic review and meta-analysis","volume":"29","author":"Vancampfort","year":"2017","journal-title":"AIDS care"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/09540121.2022.2091102","article-title":"Home-based interventions to promote physical activity for people living with HIV\u2013a systematic review","volume":"35","author":"Dos Santos","year":"2023","journal-title":"AIDS care"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110292_bib35","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1177\/10600280211073321","article-title":"Weight changes with integrase strand transfer inhibitor therapy in the management of HIV infection: a systematic review","volume":"56","author":"Hester","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110292_bib36","first-page":"8","article-title":"Dolutegravir-based or low-dose efavirenz\u2013based regimen for the treatment of HIV-1","volume":"381","year":"2019","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110292_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1902824","article-title":"Dolutegravir plus two different prodrugs of tenofovir to treat HIV","volume":"381","author":"Venter","year":"2019","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.annepidem.2026.110292_bib38","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1093\/cid\/ciaa177","article-title":"Risk factors for weight gain following switch to integrase inhibitor\u2013based antiretroviral therapy","volume":"71","author":"Lake","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110292_bib39","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/cid\/ciac355","article-title":"Integrase strand transfer inhibitors are associated with incident diabetes mellitus in people with human immunodeficiency virus","volume":"75","author":"O\u2019Halloran","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110292_bib40","first-page":"10","article-title":"Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: a longitudinal cohort study","volume":"1097","author":"Hwang","year":"2022","journal-title":"Aids"},{"key":"10.1016\/j.annepidem.2026.110292_bib41","unstructured":"North American Aids Cohort Collaboration on Research and Design (NA-ACCORD). ART Use 2026 [Available from: https:\/\/naaccord.org\/monitoring."},{"issue":"4","key":"10.1016\/j.annepidem.2026.110292_bib42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10461-019-02645-y","article-title":"Behavioral weight loss: a promising treatment for obesity in adults with HIV","volume":"24","author":"Panza","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cid\/cix238","article-title":"A randomized controlled trial of a behavioral weight loss program for human immunodeficiency virus\u2013infected patients","volume":"65","author":"Becofsky","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110292_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12937-016-0150-4","article-title":"Effects of nutrition education on weight gain prevention: a randomized controlled trial","volume":"15","author":"Metzgar","year":"2015","journal-title":"Nutr J"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/QAI.0000000000002443","article-title":"Body composition changes in response to moderate-or high-intensity exercise among older adults with or without HIV infection","volume":"85","author":"Jankowski","year":"2020","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.annepidem.2026.110292_bib46","series-title":"Open Forum Infectious Diseases","article-title":"Effects of high-intensity functional exercise on cardiorespiratory fitness and physical function in older adults with HIV: a telerehabilitation randomized trial","author":"Ryan","year":"2026"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110292_bib47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QAD.0000000000003816","article-title":"Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?","volume":"38","author":"Lee","year":"2024","journal-title":"AIDS"},{"key":"10.1016\/j.annepidem.2026.110292_bib48","doi-asserted-by":"crossref","unstructured":"Nguyen Q., Wooten D., Lee D., Moreno M., Promer K., Rajagopal A., et al. GLP-1 receptor agonists promote weight loss among people with HIV. 2024.","DOI":"10.1093\/ofid\/ofad500.109"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110292_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"New Engl J Med"},{"issue":"13","key":"10.1016\/j.annepidem.2026.110292_bib50","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110292_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2025.101363","article-title":"Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD","author":"Moolla","year":"2025","journal-title":"JHEP Rep"},{"issue":"17","key":"10.1016\/j.annepidem.2026.110292_bib52","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis","volume":"391","author":"Bliddal","year":"2024","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110292_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.7326\/M23-3354","article-title":"Open-label semaglutide reduces metabolic-associated steatotic liver disease in people with HIV: SLIM LIVER","volume":"177","author":"Lake","year":"2024","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.annepidem.2026.110292_bib54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2213-8587(24)00150-5","article-title":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","volume":"12","author":"Eckard","year":"2024","journal-title":"Lancet Diabetes & Endocrinol"},{"key":"10.1016\/j.annepidem.2026.110292_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciag337","article-title":"Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa","author":"Behuhuma","year":"2026","journal-title":"Clin Infect Dis"},{"issue":"02","key":"10.1016\/j.annepidem.2026.110292_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/a-2737-6227","article-title":"The impact of Semaglutide on weight loss and inflammation in people with HIV. An observational prospective study in Greek population","volume":"134","author":"Petrakis","year":"2026","journal-title":"Exp Clin Endocrinol & Diabetes"},{"key":"10.1016\/j.annepidem.2026.110292_bib57","unstructured":"Novo Nordisk Inc. Full prescribing information for WEGOVY. 2025."},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib58","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11154-021-09699-1","article-title":"Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes","volume":"23","author":"Mahapatra","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110292_bib59","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110292_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes & Endocrinol"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110292_bib61","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","article-title":"Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward?","volume":"13","author":"Sweatt","year":"2024","journal-title":"Curr Obes Rep"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726002905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279726002905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:59:42Z","timestamp":1793710782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279726002905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"alternative-id":["S1047279726002905"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110292","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of an early body mass index maintenance intervention at ART initiation on diabetes risk: Insights from a computer simulation study","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110292"}}